Literature DB >> 17570048

Genomic analysis of a Chinese isolate of Getah-like virus and its phylogenetic relationship with other Alphaviruses.

Jin-Sheng Wen1, Wen-Zhong Zhao, Jian-Wei Liu, Hong Zhou, Jian-Ping Tao, Hui-Jun Yan, Yu Liang, Jing-Jiao Zhou, Li-Fang Jiang.   

Abstract

An alphavirus, M-1 strain, was isolated from a pool of culicine mosquitoes collected in Hainan island of China during an arbovirus survey in 1964. In the present study, we determined the complete nucleotide sequence of the M-1 strain using RT-PCR and RACE techniques. The M-1 genome is 11,690 nucleotides (nt) in length and contains two open reading frames (ORFs) encoding four nonstructural proteins and five structural proteins, respectively. Searches using Blast and comparison analyses suggested that M-1 is closely linked to Sagiyama virus (SAGV, AB032553) with 98% identity and Getah viruse (GETV, AY702913) with 97.8% identity in the full-length nucleotide sequence. However, compared with SAGV, there is 1 deletion (3 nucleotides in length) in the Capsid region, a deletion in the 3' untranslated region (10 nucleotides in length) and 2 insertions in the 3' untranslated region involving a total of 5 nucleotides. Interestingly, from the 5' UTR to the end of coding region, M-1 share the highest identity with GETV, even though the identity of 3' UTR drops dramatically to 76.2%. Furthermore, phylogenetic analysis based on the complete genomic sequences and sequences for structural or non-structural proteins of M-1 and 15 alphaviruses showed that M-1 grouped with GETV first and then grouped together with SAGV. Based on the comparison analysis and phylogenetic analysis, we conclude that M-1 strain can be considered as a strain that is a Chinese isolate of Getah-like virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570048     DOI: 10.1007/s11262-007-0110-3

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  22 in total

1.  Evolutionary relationships and systematics of the alphaviruses.

Authors:  A M Powers; A C Brault; Y Shirako; E G Strauss; W Kang; J H Strauss; S C Weaver
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Antigenic relationships of group A arboviruses by plaque reduction neutralization testing.

Authors:  N Karabatsos
Journal:  Am J Trop Med Hyg       Date:  1975-05       Impact factor: 2.345

3.  An evolutionary tree relating eight alphaviruses, based on amino-terminal sequences of their glycoproteins.

Authors:  J R Bell; R M Kinney; D W Trent; E G Strauss; J H Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

4.  The flavivirus 3'-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus.

Authors:  G Wallner; C W Mandl; C Kunz; F X Heinz
Journal:  Virology       Date:  1995-10-20       Impact factor: 3.616

5.  Complete sequence of the genomic RNA of O'nyong-nyong virus and its use in the construction of alphavirus phylogenetic trees.

Authors:  R S Levinson; J H Strauss; E G Strauss
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

6.  Genome structure of Sagiyama virus and its relatedness to other alphaviruses.

Authors:  Y Shirako; Y Yamaguchi
Journal:  J Gen Virol       Date:  2000-05       Impact factor: 3.891

Review 7.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

8.  Arthritides caused by mosquito-borne viruses.

Authors:  R B Tesh
Journal:  Annu Rev Med       Date:  1982       Impact factor: 13.739

9.  Antigenic relationship between chikungunya virus strains and o'nyong nyong virus using monoclonal antibodies.

Authors:  N K Blackburn; T G Besselaar; G Gibson
Journal:  Res Virol       Date:  1995 Jan-Feb

10.  A comparative study of O'nyong nyong virus with Chikungunya virus and plaque variants.

Authors:  A C Chanas; Z Hubalek; B K Johnson; D I Simpson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

View more
  12 in total

1.  Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1.

Authors:  Kai Li; Haipeng Zhang; Jianguang Qiu; Yuan Lin; Jiankai Liang; Xiao Xiao; Liwu Fu; Fang Wang; Jing Cai; Yaqian Tan; Wenbo Zhu; Wei Yin; Bingzheng Lu; Fan Xing; Lipeng Tang; Min Yan; Jialuo Mai; Yuan Li; Wenli Chen; Pengxin Qiu; Xingwen Su; Guangping Gao; Phillip W L Tai; Jun Hu; Guangmei Yan
Journal:  Mol Ther       Date:  2015-09-16       Impact factor: 11.454

2.  Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous Injections.

Authors:  Haipeng Zhang; Yuan Lin; Kai Li; Jiankai Liang; Xiao Xiao; Jing Cai; Yaqian Tan; Fan Xing; Jialuo Mai; Yuan Li; Wenli Chen; Longxiang Sheng; Jiayu Gu; Wenbo Zhu; Wei Yin; Pengxin Qiu; Xingwen Su; Bingzheng Lu; Xuyan Tian; Jinhui Liu; Wanjun Lu; Yunling Dou; Yijun Huang; Bing Hu; Zhuang Kang; Guangping Gao; Zixu Mao; Shi-Yuan Cheng; Ling Lu; Xue-Tao Bai; Shoufang Gong; Guangmei Yan; Jun Hu
Journal:  Hum Gene Ther       Date:  2016-06-13       Impact factor: 5.695

3.  Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.

Authors:  Kai Li; Cheng Hu; Fan Xing; Mingshi Gao; Jiankai Liang; Xiao Xiao; Jing Cai; Yaqian Tan; Jun Hu; Wenbo Zhu; Wei Yin; Yuan Li; Wenli Chen; Bingzheng Lu; Jialuo Mai; Pengxin Qiu; Xingwen Su; Guangmei Yan; Haipeng Zhang; Yuan Lin
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

4.  Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.

Authors:  Yuan Lin; Haipeng Zhang; Jiankai Liang; Kai Li; Wenbo Zhu; Liwu Fu; Fang Wang; Xiaoke Zheng; Huijuan Shi; Sihan Wu; Xiao Xiao; Lijun Chen; Lipeng Tang; Min Yan; Xiaoxiao Yang; Yaqian Tan; Pengxin Qiu; Yijun Huang; Wei Yin; Xinwen Su; Haiyan Hu; Jun Hu; Guangmei Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

Review 5.  Newly recognized mosquito-associated viruses in mainland China, in the last two decades.

Authors:  Hong Liu; Xiaoyan Gao; Guodong Liang
Journal:  Virol J       Date:  2011-02-14       Impact factor: 4.099

6.  Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity.

Authors:  Liu Ying; Hu Cheng; Xu Wen Xiong; Lin Yuan; Zhang Hai Peng; Zhong Wen Wen; Liang Jian Ka; Xiao Xiao; Cai Jing; Tan Ya Qian; Gao Zhi Liang; Yan Guang Mei; Zhu Wen Bo; Peng Liang
Journal:  Oncotarget       Date:  2017-04-11

7.  Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.

Authors:  Cheng Hu; Ying Liu; Yuan Lin; Jian-Kai Liang; Wen-Wen Zhong; Ke Li; Wen-Tao Huang; De-Juan Wang; Guang-Mei Yan; Wen-Bo Zhu; Jian-Guang Qiu; Xin Gao
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

8.  Identification of a novel Getah virus by Virus-Discovery-cDNA random amplified polymorphic DNA (RAPD).

Authors:  Tingsong Hu; Ying Zheng; Yan Zhang; Gangshan Li; Wei Qiu; Jing Yu; Qinghua Cui; Yiyin Wang; Chaoxiong Zhang; Xiaofang Zhou; Ziliang Feng; Weiguo Zhou; Quanshui Fan; Fuqiang Zhang
Journal:  BMC Microbiol       Date:  2012-12-27       Impact factor: 3.605

9.  A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.

Authors:  Kai Li; Jiankai Liang; Yuan Lin; Haipeng Zhang; Xiao Xiao; Yaqian Tan; Jing Cai; Wenbo Zhu; Fan Xing; Jun Hu; Guangmei Yan
Journal:  Oncotarget       Date:  2016-07-26

10.  DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.

Authors:  Xiao Xiao; Jiankai Liang; Chunlong Huang; Kai Li; Fan Xing; Wenbo Zhu; Ziqing Lin; Wencang Xu; Guangen Wu; Jifu Zhang; Xi Lin; Yaqian Tan; Jing Cai; Jun Hu; Xueqin Chen; Youwei Huang; Zixi Qin; Pengxin Qiu; Xingwen Su; Lijun Chen; Yuan Lin; Haipeng Zhang; Guangmei Yan
Journal:  Nat Commun       Date:  2018-10-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.